# Sol-Millennium Medical Group

> Sol-Millennium Medical Group designs, manufactures and distributes medical devices, including safety needles and syringes, blood collection products, diabetes supplies, wound care and PPE. The Chicago-headquartered group combines precision molding roots with global manufacturing, R&D and distribution, and has expanded into needle-free insulin delivery through its relationship with NuGen.

- **Founded:** 2007
- **Headquarters:** Chicago, United States
- **Founders:** Liang Lin (Founder and CEO)
- **Products:** Sol-Care safety syringes, Sol-Guard Safety Pull-Button Blood Collection Set, Sol-Guard XtraThin Safety Pull-Button Blood Collection Set, Sol-M diabetes care, Sol-Care safety needles and infusion sets
- **Notable:** Company-reported supply of over two billion syringes and needles for global COVID-19 vaccination programs in 2021., 2022 Red Dot and iF Design recognition for the Sol-Guard pull-button blood collection set., FDA 510(k) clearance for the Sol-Guard pull-button collection set in August 2022.

## Products & services

- **Sol-Care safety syringes** — Manually retractable needles withdraw into the syringe barrel after medication delivery.
- **Sol-Guard Safety Pull-Button Blood Collection Set** — Spring-activated, in-vein needle retraction with a locking protective casing; FDA clearance K213718.
- **Sol-Guard XtraThin Safety Pull-Button Blood Collection Set** — Blood collection device cleared under K250907.
- **Sol-M diabetes care** — Insulin syringes, pen needles, lancets and lancing devices.
- **Sol-Care safety needles and infusion sets** — Protective shields lock over used needles; short-term IV infusion sets use sliding safety mechanisms.
- **Advanced wound care, PPE and veterinary supplies** — Additional consumable product categories for healthcare and veterinary users.
- **InsuJet distribution** — Needle-free insulin delivery developed by NuGen and distributed by Sol-M in designated markets.

## Achievements

- Company-reported supply of over two billion syringes and needles for global COVID-19 vaccination programs in 2021.
- 2022 Red Dot and iF Design recognition for the Sol-Guard pull-button blood collection set.
- FDA 510(k) clearance for the Sol-Guard pull-button collection set in August 2022.
- December 2025 FDA closeout letter states that violations in the March 2024 warning appear addressed.

## Latest updates

- **2026-09** — NuGen announced a September 18 loan agreement with Sol-Millennium Medical HK Limited for up to C$1.3 million, secured against NuGen assets, with staged advances and 6% annual interest.
- **2026-08** — NuGen announced a non-binding LOI to acquire Sol-Millennium Canada; the proposed terms contemplated about 65% post-transaction ownership for SolM HK, subject to conditions.
- **2026-08** — FDA recorded an August 25 substantially equivalent decision for the SOL-M Luer Lock Syringe with Exchangeable Needle Tray, K252184.
- **2025-12** — FDA closed out the March 2024 warning letter following evaluation of corrective actions.

## Links

- Website: https://solm.com/
- LinkedIn: https://www.linkedin.com/company/sol-millennium-medical-group
- YouTube: https://www.youtube.com/channel/UCPWQ8m3Bc7CPv5gfx67Rtmw
- Instagram: https://www.instagram.com/solmillennium.br/
- Facebook: https://www.facebook.com/solmillennium.br/

---

Profile page: https://yespress.io/sol-millennium-medical-group
Published by YesPress — https://yespress.io
Last updated: 2026-10-06